BofA Securities analyst Derik de Bruin reiterated a Neutral rating and $25.00 price target on 10X Genomics (NASDAQ: TXG).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE